adjustable maintenance dosing with budesonide/formoterol reduces asthma exacerbations compared with traditional fixed dosing: a five-month multicentre canadian study
Clicks: 191
ID: 229919
2003
Article Quality & Performance Metrics
Overall Quality
Not rated
Combines reader engagement with the AI quality analysis. This
article has not been analysed, so there is no overall score —
reader engagement is measured and shown alongside.
Reader Engagement
Emerging Content
30.0
/100
191 views
30 readers
AI Quality Assessment
Not analyzed
Readership in this journal
EmergingRanked #51 of 165 articles by views in religions
Most read
Least read
Bar heights use a square-root scale. Only the 120 most-read articles are drawn; the journal has 165 in total.
Mint this article as an NFT
Not yet mintedCreate a permanent, verifiable on-chain record of this article on the Scimatic Network. The NFT is held in your Journament account, and you can withdraw it to your own wallet at any time.
5
SUSD
one-off · no wallet required
Abstract
BACKGROUND: Adjustable maintenance dosing with budesonide/formoterol in a single inhaler (Symbicort, AstraZeneca, Lund, Sweden) may provide a convenient means of maintaining asthma control with the minimum effective medication level.
| Reference Key |
fitzgerlad2003canadianadjustable
Use this key to autocite in the manuscript while using
SciMatic Manuscript Manager or Thesis Manager
|
|---|---|
| Authors | ;J Mark FitzGerlad;Malcolm R Sears;Louis-Philippe Boulet;Allan B Becker;Andrew R McIvor;Pierre Ernst;Natasha M Smiljanic-Georgijev;Joanna SM Lee |
| Journal | religions |
| Year | 2003 |
| DOI |
10.1155/2003/298039
|
| URL | |
| Keywords |
Citations
No citations found. To add a citation, contact the admin at info@scimatic.org
Comments
No comments yet. Be the first to comment on this article.